COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,254 Articles (22,733 medRxiv, 8,521 bioRxiv)

Most recent first Previous |  Page 672: Articles 6711-6720  | Next

Distinguishing features of Long COVID identified through immune profiling
Klein, J., Wood, J., Jaycox, J., Lu, P., Dhodapkar, R. M., Gehlhausen, J. R., Tabachnikova, A., Tabacof, L., Malik, A. A., Kamath, K., Greene, K., Silva Monteiro, V., Pena-Hernandez, M., Mao, T., Bhattacharjee, B., Takahashi, T., Lucas, C., Silva, J., Mccarthy, D., Breyman, E., Tosto-Mancuso, J., Dai, Y., Perotti, E., Akduman, K., Tzeng, T., Xu, L., Yildirim, I., Krumholz, H. M., Shon, J., Medzhitov, R., Omer, S. B., van Dijk, D., Ring, A. M., Putrino, D., Iwasaki, A.
10.1101/2022.08.09.22278592 — Posted: 2022-08-10
Procalcitonin and High APACHE Scores are Associated with the Development of Acute Kidney Injury in Patients with SARS-CoV-2
Andrade-Sierra, J., Delgado Astorga, C., Nava Vargas, M. G., Rojas Campos, E., Hernandez Morales, K., Andrade Castellanos, C. A., Arellano Arteaga, K. J., Andrade-Ortega, A. d. J., Gonzalez-Correa, L. G.
10.1101/2022.08.09.22274874 — Posted: 2022-08-10
Antibody feedback regulation of memory B cell development in SARS-CoV-2 mRNA vaccination
Schaefer-Babajew, D., Wang, Z., Muecksch, F., Cho, A., Raspe, R., Johnson, B., Canis, M., DaSilva, J., Ramos, V., Turroja, M., Millard, K., Schmidt, F., Dizon, J., Shimeliovich, I., Yao, K.-H., Oliveira, T., Gazumyan, A., Gaebler, C., Bieniasz, P. D., Hatziioannou, T., Caskey, M., Nussenzweig, M. C.
10.1101/2022.08.05.22278483 — Posted: 2022-08-10
Anakinra in hospitalized COVID-19 patients guided by baseline soluble urokinase plasminogen receptor plasma levels: a real world, retrospective cohort study
Segala, F. V., Rando, E., Salvati, F., Negri, M., Catania, F., Sanmartin, F., Murri, R., Giamarellos-Bourboulis, E. J., Fantoni, M.
10.1101/2022.08.05.22278477 — Posted: 2022-08-10
Impact of Lifting School Masking Requirements on Incidence of COVID-19 among Staff and Students in Greater-Boston Area School Districts: A Difference-in-Differences Analysis
Cowger, T. L., Clarke, J., Murray, E. J., Sanchez, S. M., Bassett, M. T., Ojikutu, B. O., Linos, N., Hall, K. T.
10.1101/2022.08.09.22278385 — Posted: 2022-08-09
Post-acute sequelae of SARS-CoV-2 (PASC) impact quality of life at 6, 12 and 18 months post-infection
Demko, Z. O., Yu, T., Mullapudi, S. K., Varela Heslin, M. G., Dorsey, C. A., Payton, C. B., Tornheim, J. A., Blair, P. W., Mehta, S. H., Thomas, D. L., Manabe, Y. C., Antar, A. A. R., The OutSMART Study Team
10.1101/2022.08.08.22278543 — Posted: 2022-08-09
Persistent Presence of Spike protein and Viral RNA in the Circulation of Individuals with Post-Acute Sequelae of COVID-19
Craddock, V., Mahajan, A., Krishnamachary, B., Spikes, L., Chalise, P., Dhillon, N. K.
10.1101/2022.08.07.22278520 — Posted: 2022-08-09
Adjusted booster schedules disperse age-dependent differences in antibody titers benefitting risk populations - Update to: Age-dependent Immune Response to the BioNTech/Pfizer BNT162b2 Coronavirus Disease 2019 Vaccination
Müller, L., Andree, M., Moskorz, W., Drexler, I., Hauka, S., Ptok, J., Walotka, L., Grothmann, R., Hillebrandt, J., Ritchie, A., Peter, L., Walker, A., Timm, J., Adams, O., Schaal, H.
10.1101/2022.08.08.22278545 — Posted: 2022-08-09
Spike-specific CXCR3+ TFH cells play a dominant functional role in supporting antibody responses in SARS-CoV-2 infection and vaccination
Zhang, J., He, R., Liu, B., Zheng, X., Wu, Q., Wen, B., Wang, Q., Liu, Z., Chang, F., Hu, Y., Xie, T., Liu, Y., Chen, J., Yang, J., Teng, S., Bai, T., Peng, Y., Liu, Z., Peng, Y., Huang, W. J., Terzieva, V., Wang, Y., Liu, W., Li, Y.-P., Qu, X.
10.1101/2022.08.09.503302 — Posted: 2022-08-09
Cyclical Student Shifting Models in a Limited Face-to-Face Learning Modality in the time of COVID-19 Pandemic in the Philippines
Balsomo, A. J., Sabinay, S. G.
10.1101/2022.08.09.22278587 — Posted: 2022-08-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).